LOS ANGELES, CA--(Marketwire - January 24, 2008) - Auriga Laboratories, Inc. (OTCBB: ARGA), a specialty pharmaceutical company, announced today that its Board of Directors has appointed Frank R. Greico the company’s Chief Executive Officer and member of the Board of Directors (the “Board”). Three other senior executive appointments were also announced in conjunction with a reorganization of its executive management team and Board. These changes are designed to strengthen the Company’s corporate management structure and enhance its ability to fulfill its short and longer-term business objectives.
